Published in BMC Genomics on June 08, 2016
Low-dose Challenge Model With Enterotoxigenic E Coli | NCT00844493
Lung Microbiota and Its Impact on the Mucosal Immune Phenotype. Microbiol Spectr (2017) 0.75
Metagenomic analysis of the human distal gut microbiome. Science (2006) 29.76
UCHIME improves sensitivity and speed of chimera detection. Bioinformatics (2011) 29.22
Host-bacterial mutualism in the human intestine. Science (2005) 26.39
The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis. Nucleic Acids Res (2005) 24.85
Linking long-term dietary patterns with gut microbial enterotypes. Science (2011) 17.30
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol (2008) 16.57
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell (2005) 15.46
The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 13.87
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A (2010) 8.56
Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature (2014) 5.51
Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J (2010) 5.43
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology (2007) 5.04
Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev (2005) 5.02
Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A (2010) 5.02
Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell (2012) 4.86
Differential abundance analysis for microbial marker-gene surveys. Nat Methods (2013) 4.49
Reciprocal interactions of the intestinal microbiota and immune system. Nature (2012) 4.42
Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J (2007) 3.92
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog (2012) 3.81
Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology (2010) 3.68
Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev (2004) 3.61
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One (2010) 3.45
Bacterial contributions to mammalian gut development. Trends Microbiol (2004) 3.03
Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J Clin Gastroenterol (2005) 2.08
Mechanisms controlling pathogen colonization of the gut. Curr Opin Microbiol (2010) 1.88
World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010. PLoS Med (2015) 1.86
Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun (2013) 1.85
DNACLUST: accurate and efficient clustering of phylogenetic marker genes. BMC Bioinformatics (2011) 1.66
Why do African Americans get more colon cancer than Native Africans? J Nutr (2007) 1.64
Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol (2004) 1.54
Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract Res Clin Gastroenterol (2003) 1.28
Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition. Genome Biol (2014) 1.24
Recent progress toward an enterotoxigenic Escherichia coli vaccine. Expert Rev Vaccines (2012) 1.19
Enteric pathogen exploitation of the microbiota-generated nutrient environment of the gut. Curr Opin Microbiol (2011) 1.09
Intestinal bacteria and inflammatory bowel disease. Crit Rev Clin Lab Sci (2009) 1.09
Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines. Clin Vaccine Immunol (2011) 1.07
Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol (2014) 1.06
Bacteroides spp. and diarrhea. Curr Opin Infect Dis (2010) 1.02
Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods. Clin Infect Dis (2015) 0.88
Pathogenic C difficile is here (and everywhere) to stay. Lancet (2011) 0.86
Microbiota that affect risk for shigellosis in children in low-income countries. Emerg Infect Dis (2015) 0.84
Long-term antimicrobial resistance in Escherichia coli from human intestinal microbiota after administration of clindamycin. Scand J Infect Dis (2007) 0.83
Quantitative PCR and culture evaluation for enterotoxigenic Escherichia coli (ETEC) associated diarrhea in volunteers. FEMS Microbiol Lett (2014) 0.81
Status of vaccine research and development for enterotoxigenic Escherichia coli. Vaccine (2016) 0.81
Status of vaccine research and development for enterotoxigenic Escherichia coli. Vaccine (2016) 0.81
Status of vaccine research and development for Shigella. Vaccine (2016) 0.80
Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study. Lancet Infect Dis (2017) 0.75
Capturing the most wanted taxa through cross-sample correlations. ISME J (2016) 0.75
Wheat bran promotes enrichment within the human colonic microbiota of butyrate-producing bacteria that release ferulic acid. Environ Microbiol (2016) 0.75